Frontken Berhad Annual Report 2016

139

Frontken Corporation Berhad (651020-T)

ANNUAL REPORT

2016

Notes:-

1. A Member entitled to attend and vote at this meeting is entitled to appoint a proxy/proxies to attend and vote in his/her

stead. A proxy need not be a member of the Company.

2. Where a member appoints more than one (1) proxy, the appointment shall be invalid unless he specifies the proportions

of his holdings to be represented by each proxy.

3. Where the appointer is a corporation, this form must be executed under its common seal, if any or under the hand of

an officer or attorney duly authorised.

4. The instrument appointing a proxy or proxies must be deposited at the office of the Share Registrar of the Company

situated at Unit 32-01, Level 32, Tower A, Vertical Business Suite, Avenue 3, Bangsar South, No. 8, Jalan Kerinchi, 59200

Kuala Lumpur not less than forty-eight (48) hours before the time fixed for convening the Meeting or any adjournment

thereof.

5. For the purpose of determining a member who shall be entitled to attend the Thirteenth Annual General Meeting, the

Company shall request Bursa Malaysia Depository Sdn Bhd to issue a Record of Depositors as at 24 May 2017. Only

a depositor whose name appears on the Record of the Depositor as at 24 May 2017 shall be entitled to attend this

Thirteenth Annual General Meeting or appoint proxies to attend and/or vote on his/her behalf

6. All resolutions at the Annual General Meeting shall be voted by poll.

Explanatory Notes on Ordinary Business:-

Item 1 of the Agenda

This Agenda item is meant for discussion only as the provision of Section 340(1)(a) of the Act does not require a formal

approval of the shareholders for the Audited Financial Statements. Hence, this item is not put forward to shareholders

for voting.

Item 3 of the Agenda

Section 230(1) of the Act requires that the fees of the directors and any benefits payable to the directors be approved at a

general meeting. The benefits comprised of meeting allowance, travelling allowance and Board Committee allowances.

Explanatory Note on Special Business:-

Item 5 of the Agenda

The proposed Ordinary Resolution 5, if passed, will empower the Directors from the conclusion of this AGM, to allot

and issue up to a maximum of 10% of the total issued and paid-up share capital of the Company (excluding treasury

shares) at the time of issue (other than bonus or rights issue) without the need to convene a general meeting and for

such purposes as they consider would be in the best interest of the Company. This authority, unless revoked or varied

at a general meeting, will expire at the next AGM of the Company. This mandate will provide flexibility to the Company

for any possible fund raising activities, including but not limited to placing of shares, for the purpose of funding working

capital, future investment project(s) and/or acquisition(s). At this juncture, there is no decision to issue new shares.

If there should be a decision to issue any new share after the general mandate is sought, the Company will make an

announcement in respect thereof.

The proposed Ordinary Resolution 5 is a renewal of the general mandate for issuance of shares pursuant to Sections

75 and 76 of the Act. The Company had, at the Twelfth AGM held on 24 June 2016, obtained its shareholders’ approval

for the general mandate for issuance of shares pursuant to Section 132D of the Companies Act 1965. As at the date of

this notice, the Company did not issue any share pursuant to the said mandate.

Notice Of Annual General Meeting

(cont’d)